NATHBIOGEN Share Price Target 2050

CAGR-based price projection for Nath Bio-Genes (India) Limited (NATHBIOGEN) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (-4.0% CAGR)
Rs 52
2050 Target
Base Case (-9.9% CAGR)
Rs 11
2050 Target
Bull Case (-14.9% CAGR)
Rs 3
2050 Target

Current Market Snapshot

CMP: Rs 137.74
52W High: Rs 196.01
52W Low: Rs 137.74
1Y CAGR: -18.9%
3Y CAGR: -9.9%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 132 Rs 124 Rs 117
2028 Rs 127 Rs 112 Rs 100
2029 Rs 122 Rs 101 Rs 85
2030 Rs 117 Rs 91 Rs 72
2031 Rs 112 Rs 82 Rs 61
2032 Rs 108 Rs 74 Rs 52
2033 Rs 104 Rs 66 Rs 44
2034 Rs 100 Rs 60 Rs 38
2035 Rs 96 Rs 54 Rs 32
2036 Rs 92 Rs 48 Rs 27
2037 Rs 88 Rs 44 Rs 23
2038 Rs 85 Rs 39 Rs 20
2039 Rs 81 Rs 35 Rs 17
2040 Rs 78 Rs 32 Rs 14
2041 Rs 75 Rs 29 Rs 12
2042 Rs 72 Rs 26 Rs 10
2043 Rs 69 Rs 23 Rs 9
2044 Rs 66 Rs 21 Rs 8
2045 Rs 64 Rs 19 Rs 6
2046 Rs 61 Rs 17 Rs 5
2047 Rs 59 Rs 15 Rs 5
2048 Rs 56 Rs 14 Rs 4
2049 Rs 54 Rs 12 Rs 3
2050 Rs 52 Rs 11 Rs 3

Other NATHBIOGEN Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the NATHBIOGEN share price target for 2050?

Based on historical growth analysis, the NATHBIOGEN share price target for 2050 ranges from Rs 52 (conservative) to Rs 11 (base case) to Rs 3 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of NATHBIOGEN?

The current market price of NATHBIOGEN (Nath Bio-Genes (India) Limited) is Rs 137.74. The 52-week high is Rs 196.01 and 52-week low is Rs 137.74.

Is NATHBIOGEN a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for NATHBIOGEN price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -4.0% CAGR), Base (-9.9% CAGR), and Bull (optimistic at -14.9% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.